Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RVMD Revolution Medicines, Inc.

盘前交易 12-30 05:39:58 EST

80.52

-0.23

-0.28%

最高80.93	最低79.80	成交量203.52万
今开80.01	昨收80.75	日振幅1.39%
总市值155.66亿	流通市值132.86亿	总股本1.93亿
成交额1.64亿	换手率1.23%	流通股本1.65亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RVMD","market":"US","secType":"STK","nameCN":"Revolution Medicines, Inc.","latestPrice":80.52,"timestamp":1767042000000,"preClose":80.75,"halted":0,"volume":2035208,"delay":0,"floatShares":165000000,"shares":193319805,"eps":-5.193111,"marketStatus":"盘前交易","change":-0.23,"latestTime":"12-30 05:39:58 EST","open":80.01,"high":80.925,"low":79.8,"amount":163819509.09408,"amplitude":0.013932,"askPrice":82.99,"askSize":160,"bidPrice":80.01,"bidSize":426,"shortable":3,"etf":0,"ttmEps":-5.193111,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767105000000},"marketStatusCode":1,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":80.52,"postHourTrading":{"tag":"盘后","latestPrice":80.52,"preClose":80.52,"latestTime":"18:27 EST","volume":340555,"amount":27421489.62,"timestamp":1767050845829},"volumeRatio":0.8661158363801227,"impliedVol":0.597,"impliedVolPercentile":0.8635},"requestUrl":"/m/hq/s/RVMD","defaultTab":"news","newsList":[{"id":"2594424505","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌6.26%报0.900美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594424505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594424505?lang=zh_cn&edition=full","pubTime":"2025-12-27 02:11","pubTimestamp":1766772672,"startTime":"0","endTime":"0","summary":"北京时间2025年12月27日02时11分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价急速跳水6.26%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.35%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227021112a47c8c3a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251227021112a47c8c3a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2592575161","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫23.27% 市值跌2922.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592575161","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592575161?lang=zh_cn&edition=full","pubTime":"2025-12-19 01:40","pubTimestamp":1766079654,"startTime":"0","endTime":"0","summary":"北京时间2025年12月19日01时40分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速跳水23.27%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.44%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219014055a6b38498&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219014055a6b38498&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0},{"id":"1168747505","title":"Revolution Medicines宣布Rasolute 304临床试验中第一位随机患者的入组，该试验针对在辅助化疗后可切除胰腺导管腺癌使用Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=1168747505","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168747505?lang=zh_cn&edition=full","pubTime":"2025-12-18 21:03","pubTimestamp":1766062992,"startTime":"0","endTime":"0","summary":"Revolution Medicines宣布Rasolute 304临床试验中第一位随机患者的入组，该试验针对在辅助化疗后可切除胰腺导管腺癌使用Daraxonrasib","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2586544035","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘大幅拉升7.09%报0.600美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586544035","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586544035?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:30","pubTimestamp":1763994628,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日22时30分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速上涨7.09%。截至发稿，该股报0.600美元/股，成交量1022股，换手率0.00%，振幅0.00%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.00%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223029a4b75243&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251124223029a4b75243&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","RVMDW","BK4139"],"gpt_icon":0},{"id":"2581963850","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 早盘大幅拉升5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581963850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581963850?lang=zh_cn&edition=full","pubTime":"2025-11-07 22:43","pubTimestamp":1762526605,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日22时43分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价急速上涨5.26%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为0.61%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722432594f5ed10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110722432594f5ed10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"1162551616","title":"Revolution Medicines第三季度每股收益为-1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1162551616","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162551616?lang=zh_cn&edition=full","pubTime":"2025-11-06 05:19","pubTimestamp":1762377577,"startTime":"0","endTime":"0","summary":"11月5日 - Revolution Medicines第三季度税前利润为-3.05206亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2580103204","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 急速上涨7.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580103204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580103204?lang=zh_cn&edition=full","pubTime":"2025-11-04 00:48","pubTimestamp":1762188483,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日00时48分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现异动，股价快速拉升7.11%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为1.38%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104004803a4859ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104004803a4859ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"2576096134","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫15.38% 市值涨2225.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576096134","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576096134?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:00","pubTimestamp":1760709629,"startTime":"0","endTime":"0","summary":"北京时间2025年10月17日22时00分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价大幅下挫15.38%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.28%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101722002994cf46ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101722002994cf46ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","RVMDW","BK4139"],"gpt_icon":0},{"id":"1151488115","title":"FDA：预计在未来几个月内公布另一批专员国家优先券的接受者","url":"https://stock-news.laohu8.com/highlight/detail?id=1151488115","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151488115?lang=zh_cn&edition=full","pubTime":"2025-10-17 05:23","pubTimestamp":1760649791,"startTime":"0","endTime":"0","summary":"FDA：预计在未来几个月内公布另一批专员国家优先券的接受者","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","IRON","LU0109394709.USD","LU2089984988.USD","BK4588","LU0053666078.USD","BK4139","LU2362540622.SGD","LU2468319806.SGD","LU0889565916.HKD","LU0882574055.USD","ACHV","LU2023250504.SGD","LU0289739699.SGD","REGN","LU0823434740.USD","LU0058720904.USD","LU0823434583.USD","RVMD","LU0114720955.EUR","LU1974910355.USD","LU2362541273.HKD","LU1917777945.USD","LU2106854487.HKD","LU2237438978.USD","LU0823416689.USD","LU0320765992.SGD","BK4585"],"gpt_icon":0},{"id":"2573626922","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大涨7.31%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573626922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573626922?lang=zh_cn&edition=full","pubTime":"2025-10-08 22:05","pubTimestamp":1759932323,"startTime":"0","endTime":"0","summary":"北京时间2025年10月08日22时05分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价快速拉升7.31%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.25%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008220524a6b0d572&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008220524a6b0d572&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139","RVMDW"],"gpt_icon":0},{"id":"2572570583","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 股价大跌6.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572570583","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572570583?lang=zh_cn&edition=full","pubTime":"2025-10-03 00:47","pubTimestamp":1759423637,"startTime":"0","endTime":"0","summary":"北京时间2025年10月03日00时47分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价快速下跌6.90%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为0.54%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003004717971d7585&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251003004717971d7585&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","RVMD","BK4139"],"gpt_icon":0},{"id":"2571366613","title":"Revolution Medicines, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571366613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571366613?lang=zh_cn&edition=full","pubTime":"2025-09-29 23:55","pubTimestamp":1759161319,"startTime":"0","endTime":"0","summary":"北京时间2025年09月29日23时55分，Revolution Medicines, Inc.股票出现波动，股价快速拉升5.01%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体涨幅为1.54%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929235519a6a6a271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929235519a6a6a271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"1167803578","title":"Revolution Medicines宣布重要领导层人事任命，Alan Sandler医学博士出任首席开发官","url":"https://stock-news.laohu8.com/highlight/detail?id=1167803578","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167803578?lang=zh_cn&edition=full","pubTime":"2025-09-29 21:03","pubTimestamp":1759150996,"startTime":"0","endTime":"0","summary":"Revolution Medicines宣布重要领导层人事任命，Alan Sandler医学博士出任首席开发官","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"1111783191","title":"Revolution Medicines, Inc.公布新临床结果，支持启动Rasolute 303全球3期注册试验，评估Daraxonrasib用于一线转移性胰腺导管腺癌治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1111783191","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111783191?lang=zh_cn&edition=full","pubTime":"2025-09-11 04:03","pubTimestamp":1757534595,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc.公布新临床结果，支持启动Rasolute 303全球3期注册试验，评估Daraxonrasib用于一线转移性胰腺导管腺癌治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2560710120","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)股价重挫12.39% 市值跌3353.58万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560710120","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560710120?lang=zh_cn&edition=full","pubTime":"2025-08-20 02:15","pubTimestamp":1755627303,"startTime":"0","endTime":"0","summary":"北京时间2025年08月20日02时15分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价大幅跳水12.39%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为2.00%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820021503a4924a3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250820021503a4924a3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD"],"gpt_icon":0},{"id":"2558574151","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 快速下挫6.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558574151","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558574151?lang=zh_cn&edition=full","pubTime":"2025-08-09 03:44","pubTimestamp":1754682249,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日03时44分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价快速跳水6.92%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体跌幅为1.24%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080903440994d85dd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080903440994d85dd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMDW","BK4139","RVMD"],"gpt_icon":0},{"id":"1189426371","title":"异动解读 | Revolution Medicines股价盘中大跌6.79%，二季度巨额亏损引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1189426371","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189426371?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:46","pubTimestamp":1754574388,"startTime":"0","endTime":"0","summary":"周四盘中，生物制药公司Revolution Medicines, Inc.股价大跌6.79%，引发市场广泛关注。这一显著跌幅似乎与公司最新公布的第二季度财务业绩密切相关。根据Revolution Medicines发布的财报，公司第二季度每股亏损高达1.31美元，远超市场预期。更值得注意的是，Revolution Medicines预计全年净亏损将在10.3亿至10.9亿美元之间，这一前景让投资者对公司的财务状况和未来盈利能力产生了担忧。作为一家专注于开发靶向治疗癌症的创新药物的生物技术公司，Revolution Medicines的高额研发支出在业内并不罕见。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RVMD"],"gpt_icon":0},{"id":"1107909772","title":"异动解读 | Revolution Medicines盘中大跌6.79%，第二季度亏损扩大引发投资者担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1107909772","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107909772?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:45","pubTimestamp":1754574319,"startTime":"0","endTime":"0","summary":"生物制药公司Revolution Medicines, Inc.今日盘中股价大跌6.79%，引发市场广泛关注。这一显著跌幅很可能与公司最新发布的第二季度财报有关。根据Revolution Medicines公布的财报显示，公司第二季度每股亏损1.31美元，净亏损高达2.478亿美元。更令投资者担忧的是，公司预计全年净亏损将在10.3亿至10.9亿美元之间，显示出亏损可能进一步扩大的趋势。这份令人失望的财报数据无疑打击了投资者信心。生物制药行业的研发投入通常较大，但Revolution Medicines的亏损规模和持续时间似乎超出了市场预期。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["RVMD"],"gpt_icon":0},{"id":"2557301044","title":"Revolution Medicines, Inc.盘中异动 下午盘股价大跌5.03%报36.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557301044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557301044?lang=zh_cn&edition=full","pubTime":"2025-08-07 02:45","pubTimestamp":1754505903,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日02时45分，Revolution Medicines, Inc.股票出现异动，股价大幅下跌5.03%。截至发稿，该股报36.46美元/股，成交量95.9721万股，换手率0.52%，振幅4.74%。Revolution Medicines, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Revolution Medicines, Inc.公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070245049737fa2e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508070245049737fa2e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RVMD","BK4139"],"gpt_icon":0},{"id":"2557354963","title":"Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)盘中异动 下午盘急速拉升7.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557354963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557354963?lang=zh_cn&edition=full","pubTime":"2025-08-05 02:11","pubTimestamp":1754331061,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日02时11分，Revolution Medicines Inc C/Wts 17/12/2026 股票出现波动，股价快速拉升7.71%。Revolution Medicines Inc C/Wts 17/12/2026 股票所在的生物技术行业中，整体涨幅为1.38%。Revolution Medicines Inc C/Wts 17/12/2026 公司简介：Revolution Medicines Inc是一家临床阶段的精密肿瘤学公司，致力于开发新颖的靶向疗法，以抑制臭名昭著的生长和生存途径内的难以捉摸的前沿靶标，尤其侧重于RAS和mTOR信号通路。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805021101a474e46d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805021101a474e46d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RVMD","RVMDW"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.revmed.com","stockEarnings":[{"period":"1week","weight":-0.0007},{"period":"1month","weight":0.0355},{"period":"3month","weight":0.7242},{"period":"6month","weight":1.1651},{"period":"1year","weight":0.8213},{"period":"ytd","weight":0.8409}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.0065},{"period":"3month","weight":0.0325},{"period":"6month","weight":0.1086},{"period":"1year","weight":0.156},{"period":"ytd","weight":0.1736}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Revolution Medicines, Inc.成立于2014年10月，是特拉华州的一家公司。该公司是一家临床阶段的精准肿瘤学公司，专注于开发靶向疗法，以抑制RAS成瘾癌症的前沿靶点。该公司拥有先进的基于结构的药物发现能力，其基础是深厚的化学生物学和癌症药理学知识以及创新的专有技术，能够创造适合非常规结合位点的小分子。该公司对癌症的遗传驱动因素和适应性耐药机制的了解，加上强大的药物发现和药物化学能力，指导建立了一个针对RAS通路和相关通路中的关键信号节点的深层管道。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.001701},{"month":2,"riseRate":0.6,"avgChangeRate":-0.005035},{"month":3,"riseRate":0.5,"avgChangeRate":-0.029333},{"month":4,"riseRate":0.666667,"avgChangeRate":0.052764},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.03349},{"month":6,"riseRate":0.833333,"avgChangeRate":0.042659},{"month":7,"riseRate":0.5,"avgChangeRate":-0.000709},{"month":8,"riseRate":0.666667,"avgChangeRate":0.059948},{"month":9,"riseRate":0.5,"avgChangeRate":0.038151},{"month":10,"riseRate":0.666667,"avgChangeRate":0.019949},{"month":11,"riseRate":0.833333,"avgChangeRate":0.188424},{"month":12,"riseRate":0.5,"avgChangeRate":-0.025327}],"exchange":"NASDAQ","name":"Revolution Medicines, Inc.","nameEN":"Revolution Medicines, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Revolution Medicines, Inc.,RVMD,Revolution Medicines, Inc.股票,Revolution Medicines, Inc.股票老虎,Revolution Medicines, Inc.股票老虎国际,Revolution Medicines, Inc.行情,Revolution Medicines, Inc.股票行情,Revolution Medicines, Inc.股价,Revolution Medicines, Inc.股市,Revolution Medicines, Inc.股票价格,Revolution Medicines, Inc.股票交易,Revolution Medicines, Inc.股票购买,Revolution Medicines, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Revolution Medicines, Inc.(RVMD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Revolution Medicines, Inc.(RVMD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}